Lethal effects of the combination of hyperthermia and bromocriptine or a somatostatin analogue on normal pituitary cells and pituitary tumour cells

Int J Hyperthermia. 1992 Nov-Dec;8(6):747-54. doi: 10.3109/02656739209005022.

Abstract

Effects of hyperthermia alone and combined with bromocriptine (BC) or a somatostatin analogue (SMS 201-995) were studied in vitro on normal pituitary and pituitary tumour cells (GH3 cells). GH3 cells were more sensitive to heat than normal pituitary cells and a maximal difference in survival was obtained with hyperthermia at 42.5 degrees C for 6 h. BC had cytotoxic and antiproliferative effects on GH3 cells, whereas SMS 201-995 was not effective. Hyperthermia at 42.5 degrees C for 3 h in combination with BC enhanced selective cytotoxicity for GH3 cells. In contrast, combined treatment with hyperthermia and SMS 201-995 failed to enhance cytotoxicity for GH3 cells. The combination of hyperthermia and BC could provide improved therapeutic efficacy in patients with pituitary adenomas.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bromocriptine / pharmacology*
  • Cell Survival / drug effects
  • Combined Modality Therapy
  • DNA / biosynthesis
  • DNA, Neoplasm / biosynthesis
  • Female
  • Hot Temperature
  • Hyperthermia, Induced*
  • In Vitro Techniques
  • Octreotide / pharmacology*
  • Pituitary Gland / cytology
  • Pituitary Gland / drug effects
  • Pituitary Gland / metabolism
  • Pituitary Neoplasms / drug therapy*
  • Pituitary Neoplasms / metabolism
  • Pituitary Neoplasms / therapy*
  • Rats
  • Rats, Wistar
  • Tumor Cells, Cultured / drug effects
  • Tumor Cells, Cultured / metabolism
  • Tumor Cells, Cultured / pathology

Substances

  • DNA, Neoplasm
  • Bromocriptine
  • DNA
  • Octreotide